U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777523) titled 'Non-invasive Testing for End-Stage Chronic Kidney Disease' on Aug. 13.
Brief Summary: This study evaluates the clinical performance of a non-invasive digital diagnostic test (KF4+, developed and manufactured by Gisens Biotech) for the measurement of urea and potassium in capillary blood in patients with end-stage renal disease (ESRD) undergoing dialysis. Measurements obtained using the KF4+ test in capillary blood are compared with hospital laboratory reference methods performed on venous blood samples. The study also assesses the feasibility of determining dialysis efficiency, expressed as Kt/V, using non-invasive samples. The obje...